Mykare Health is an Indian startup that has quickly gained recognition as the country's fastest-growing elective surgery platform. Founded in 2021, the company has already made a significant impact, having reached 70,000+ patients across 12+ Indian cities, offering services in 60+ hospitals with a total capacity of 2000+ beds. Additionally, they have provided care to over 5000 international patients and boast a dedicated team of 60+ members.
The company's value propositions include 24x7 quality care, complete price transparency, zero-cost financing options, and administrative support, aiming to address the issues of accessibility and financing within the industry. Mykare operates through an asset-light model, providing elective surgeries at a 20-30% discount by leveraging the underutilized infrastructure capacity of hospitals and surgeons.
The $2.00M Seed Round investment at 15 June 2023 has demonstrated confidence in the company, with notable investors such as Huddle, Avaana Capital, Phoenix Angels, Endurance Capital, Nikhil Jaisinghani, Stanford Angels and Entrepreneurs India, Deepu Sebin, Vikas Garg, F Health, and Arjun Vaidya supporting the vision.
Recognized as the Best Startup of the Year 2022 by Tie and Sambharabham Business Magazine, and acknowledged as a Startup to Watch by Inc42, Mykare Health has positioned itself as a leading player in the Indian healthcare industry, offering trusted, affordable, and accessible services.
